Refining Treatment Options for Trichomonas Vaginalis Infection in Women and Men: A Comparative Analysis of Oral Multi-Dose Metronidazole and Single-Dose Secnidazole
This is a multi-centered, randomized, open-label, parallel, phase IV clinical trial comparing the effectiveness and cost-effectiveness of oral multi-dose metronidazole (MTZ) and oral single-dose secnidazole (SEC) for the treatment of Trichomonas vaginalis in both women and men.
100 Clinical Results associated with Healthcare Clinical Data, Inc.
0 Patents (Medical) associated with Healthcare Clinical Data, Inc.
100 Deals associated with Healthcare Clinical Data, Inc.
100 Translational Medicine associated with Healthcare Clinical Data, Inc.